This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
Data from up to 5,000 adult patients in the US will be captured from eligible patients
enrolled following admission to the hospital. Participants will have de-identified medical
records collected from hospital admission to discharge, including but not limited to critical
care monitoring, details on mechanical ventilation, laboratory data, imaging reports,
medications, and all procedures. Diagnosis and patient management will follow each hospital's
standard of care and no specific treatments, procedures or laboratory tests will be dictated
by enrollment in TARGET-COVID-19.
Inclusion Criteria:
- Adults (age ≥18 years) who are or have been hospitalized and diagnosed with Severe
Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection.
- SARS-CoV-2 confirmed diagnosis (e.g. polymerase chain reaction [PCR] or other
clinically utilized test).
Exclusion Criteria:
N/A
University of Washington
Seattle, Washington, United States
Chuck Moser
984-234-0268
cmoser@targetpharmasolutions.com